ADT, BMW and Duchossois Group have achieved exits after people-tracking app developer Life360 became one of the few US-based companies to float in Australia.
Author: Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Greensill leans into $800m Vision Fund investment
SoftBank Vision Fund is investing $800m in Greensill, a platform that provides working capital to businesses, at a reported $3.5bn valuation.
CEC electrifies Qianxin with $542m
Qihoo 360 spinoff Beijing Qianxin Technology has received approximately $542m from China Electronics Corporation at a valuation of $2.4bn.
Harry’s edges towards $1.37bn acquisition
Edgewell Personal Care has agreed to acquire razor subscription service Harry’s in a cash and stock transaction that will allow Grace Beauty Capital to exit.
Milestone Pharmaceuticals progresses to flotation
Milestone, a cardiovascular nasal spray developer that raised more than $167m in VC funding from investors including Novo, secured $82.5m in when it went public.
Altiostar shines in $114m series C round
Network technology provider Altiostar has closed a $114m series C round after Rakuten added to Qualcomm Ventures and Tech Mahindra’s contributions.
Suning partners Yunfeng for $2.5bn fund
Suning has joined forces with Yunfeng Capital, the private equity firm co-founded by Alibaba founder Jack Ma, committing up to $210m to a fund that is targeting a $2.5bn close.
Byton moves closer to $500m series C
FAW Group will reportedly provide $100m for Byton for a $500m round likely to value the electric SUV developer at more than $2.5bn.
Gett gains $200m at $1.5bn valuation
All Gett’s existing investors, including Volkswagen and Access Industries, have participated in a $120m extension that brought its latest round to $200m.
Vay Sports kicks off with corporate funds
University of Zurich spinout Vay Sports has launched having raised an undisclosed amount from investors including Swisscom and WelcomeAI.
Douyu pauses $500m IPO plans
Tencent will have to wait a little longer to exit livestreaming platform Douyu, which has decided to delay its initial public offering due to American tariffs on Chinese goods.
Tot Biopharm targets Honk Kong listing
Center Laboratories Group and Formosa Laboratories are in line for exits as cancer drug developer Tot Biopharm aims to go public.
Deskera extends series A past $100m
Deskera has pushed its SIG and Cisco-backed series A round beyond $100m, after securing more than $40m in an extension led by Mirae Asset – Naver Asia Growth Fund.
TransMedics traps $91m in initial public offering
Pharmstandard, Lung Biotechnology and Posco celebrated exits as the organ transportation system developer went public in a $91m offering.